XWELL, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XWEL research report →
Price Chart
About the company
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe.
- CEO
- Ezra T. Ernst
- IPO
- 2010
- Employees
- 175
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on XWEL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.28M
- P/E
- -0.17
- PEG
- 0.00
- P/S
- 0.26
- P/B
- -3.94
- EV/EBITDA
- -0.13
- Div Yield
- 0.00%
- Gross Margin
- 30.69%
- Op Margin
- -24.14%
- Net Margin
- -82.81%
- ROE
- 317.52%
- ROIC
- -43.92%
Latest fiscal year · YoY change
- Revenue
- $29.21M-13.8%
- Gross Profit
- $6.64M-25.5%
- Op Income
- $-9,356,000
- Net Income
- $-16,991,000-0.8%
- EPS
- $-5.08-38.8%
- OCF Growth
- +20.8%
- FCF Growth
- +8.8%
- 52W High
- $2.20
- 52W Low
- $0.26
- 50D MA
- $0.95
- 200D MA
- $0.99
- Beta
- 0.94
- RSI (14)
- 53
- Avg Volume
- 36.45K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
XWELL posted higher third-quarter revenue and narrower losses as management pushed a cost-cutting, growth-through-new-locations strategy.· November 14, 2024
- Q3 revenue rose to approximately $8.4 million from $7.5 million a year ago.
- Operating loss improved to $4.8 million from $12.1 million, and net loss attributable to common shareholders narrowed to $4.8 million from $11.5 million.
- Management said nine-month 2024 operating expenses fell about 35% year over year, with cost of sales down about 6% and G&A down about 5%.
- The company is leaning into out-of-airport growth, including Florida expansion, a Naples Wax opening in November, and a Penn Station XpresSpa planned for next year.
- Balance sheet liquidity was described as solid, with $4.4 million of cash, $11.7 million of marketable securities, and no long-term debt.
For the third quarter, revenue was approximately $8.4 million versus $7.5 million in the prior-year period. Revenue came from approximately $4.9 million at XpresSpa and Treat locations, approximately $3.1 million from XpresTest (including the biosurveillance partnership and HyperPointe), and approximately $0.4 million from Naples Wax Center. Operating loss improved to $4.8 million from $12.1 million, and net loss attributable to common shareholders improved to $4.8 million from $11.5 million. Total operating expenses were approximately $6.8 million versus approximately $13.2 million a year ago. On the balance sheet, cash and cash equivalents were $4.4 million, marketable securities were $11.7 million, total current assets were approximately $19.5 million, and the company had no long-term debt. Management did not provide formal next-quarter or full-year revenue/EPS guidance on this call, but said it expects continued cost reduction and better bottom-line performance as it moves through 2025.
Ezra Ernst framed the quarter as evidence that the company is becoming leaner and more agile after consolidating the dual-CEO structure, saying the move supports cost reduction and a return to profitability. He highlighted growth initiatives in out-of-airport wellness, especially Florida expansion, with up to 10 XWELL properties expected by mid-2025 and a first Naples Wax opening in November. He also pointed to solid early traction at the Philadelphia airport spa, promising performance from autonomous massage chairs and robotic nail systems, and a Penn Station XpresSpa planned for next year.
Suzanne Scrabis said Q3 revenue was approximately $8.4 million, up from $7.5 million, and broke out the revenue mix across XpresSpa/Treat, XpresTest, and Naples Wax Center. She noted salaries and benefits were approximately $1.9 million versus $1.2 million last year, but said the prior-year quarter included about $1 million of non-recurring ERC credit; excluding that item, salaries and benefits would have decreased 4% year over year. She also said G&A was approximately $4.5 million, including more than $2 million of extraordinary legal expenses, total operating expenses were approximately $6.8 million versus $13.2 million, and the company ended with $4.4 million of cash, $11.7 million of marketable securities, and no long-term debt.
There was no analyst Q&A in the transcript. Management’s commentary focused instead on strategy and operating updates, including cost discipline, new store openings, and the early performance of tech-forward airport concepts. The only forward-looking color was qualitative: continued execution, prudent cost management, and better operating efficiency into 2025.
The bullish case is that revenue grew year over year while losses and operating expenses fell sharply, suggesting the cost-reset is taking hold. Management also described multiple growth vectors — Florida expansion, a Naples Wax opening, Penn Station, and tech-enabled airport concepts — with solid early traction at Philadelphia and benefits from the Priority Pass partnership.
The bear case is that the company is still losing money and remains exposed to relatively small-scale revenue generation, with no formal financial guidance provided. Legal expenses were still elevated at more than $2 million in G&A, and management’s growth plans depend on successful execution across new locations and formats rather than on established recurring momentum.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 81.3%
- Shares Outstanding
- 7.93M
- Float Shares
- 6.45M
of shares held by institutions
17 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Citadel Advisors LLC | 117.02K | ▲ 117.02K |
| Wealthspire Advisors, LLC | 105.10K | ▲ 105.10K |
| Blackrock, Inc. | 81.99K | 0 |
| Vanguard Group Inc | 77.07K | 0 |
| Geode Capital Management, LLC | 56.07K | ▼ 11.46K |
| Vanguard Capital Management LLC | 51.31K | 0 |
| Xtx Topco Ltd | 32.77K | ▲ 32.77K |
| Jane Street Group, LLC | 31.22K | ▼ 50.94K |
| Vanguard Fiduciary Trust Co | 23.38K | 0 |
| State Street Corp | 16.14K | 0 |
| Integrated Wealth Concepts LLC | 10.35K | 0 |
| Citigroup Inc | 6.19K | ▲ 3.62K |
Held by 6 ETFs
Biggest fund positions in XWEL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 25, 26 | Reid Gerard | other | 150,000 |
| Aug 3, 26 | Reid Gerard | other | 0 |
| Aug 25, 26 | Wizenberg Gaelle Sandra | other | 50,000 |
| Aug 25, 26 | WEINSTEIN ROBERT | other | 50,000 |
| Aug 25, 26 | Bernstein Bruce | other | 500,000 |
| Aug 25, 26 | Lebowitz Michael | other | 50,000 |
| Feb 27, 26 | WEINSTEIN ROBERT | other | 100,000 |
| Feb 27, 26 | Lebowitz Michael | other | 100,000 |
| Feb 27, 26 | Ernst Ezra | other | 100,000 |
| Feb 27, 26 | Bernstein Bruce | other | 100,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our XWEL coverage
Recent articles, reports, and earnings notes.
No research on XWEL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XWEL report →XWELL Appoints Global Energy and Capital Markets Leader Gerard Reid to its Board of Directors
globenewswire.com · Aug 5
XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses
globenewswire.com · Jul 7
Head-To-Head Analysis: XWELL (NASDAQ:XWEL) versus HealthEquity (NASDAQ:HQY)
defenseworld.net · Apr 13
Head-To-Head Analysis: XWELL (NASDAQ:XWEL) & Organon & Co. (NYSE:OGN)
defenseworld.net · Apr 10
XWELL Reports Fiscal 2025 Results
globenewswire.com · Apr 1
XWELL, Inc. (NASDAQ:XWEL) Short Interest Down 78.7% in March
defenseworld.net · Mar 27
Head to Head Survey: iSpecimen (NASDAQ:ISPC) & XWELL (NASDAQ:XWEL)
defenseworld.net · Mar 23
Financial Contrast: XWELL (NASDAQ:XWEL) versus Avantor (NYSE:AVTR)
defenseworld.net · Mar 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.